DEERFIELD MANAGEMENT COMPANY, L.P.
New York, NY · CIK 1009258 · 13F filing filed 2023-08-14
SEC-registered investment adviser since 2012 · limited partnership
- Assets managed$19.1bn
- Staff189 · 89 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds12 (11 hedge) · $19.2bn gross assets
- Form ADV · 2026-07-31SEC adviser record
- Legal entityDEERFIELD MANAGEMENT COMPANY, L.P. (US)
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY, Parsippany, NJ
As an employer
- Offices in1 country
- Private fundshedge 11, private equity 1
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 86 |
| Parsippany, NJUnited States | 3 |
US visa salary filings
- Filings FY2024–20266
- Median salary offered$160,000
- Middle half$140,000 – $191,250
- Job titles5
| Job title | Filings | Median |
|---|---|---|
| AnalystNew York, NY | 2 | $140,000 |
| Data EngineerNew York, NY | 1 | $210,000 |
| Senior Director, Business IntelligenceNew York, NY | 1 | $195,000 |
| Director, Business IntelligenceNew York, NY | 1 | $180,000 |
| Market Research AssociateNew York, NY | 1 | $80,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Deerfield Management Company, L.P..
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
This report includes the holdings of 1 other manager that shares the investment decisions:
- Flynn Management LLC – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NUVALENT INC COM | $843.0m18.00% | Unchanged |
| GLAUKOS CORP GKOS 2.75 06.15.27 · principal | $412.7m8.81% | Reduced -300.0k |
| VIATRIS INC VTRS | $176.7m3.77% | Added +767.5k |
| AMEDISYS INC AMED | $164.0m3.50% | Added +310.8k |
| NATERA INC NTRA 2.25 05.01.27 · principal | $146.9m3.14% | Unchanged |
| ADAPTHEALTH CORP AHCO | $135.0m2.88% | Added +500.0k |
| IONIS PHARMACEUTICALS INC IONS 0 04.01.26 · principal | $121.0m2.58% | Unchanged |
| TABULA RASA HEALTHCARE INC TRHC 1.75 02.15.26 · principal | $120.0m2.56% | Unchanged |
| BROOKDALE SR LIVING INC BKD 2 10.15.26 · principal | $114.8m2.45% | Unchanged |
| NEUROCRINE BIOSCIENCES INC NBIX | $114.1m2.44% | Reduced -535.0k |
| CATALYST PHARMACEUTICALS INC CPRX | $110.1m2.35% | Reduced -2.2m |
| ACCOLADE INC ACCD 0.5 04.01.26 · principal | $102.1m2.18% | Unchanged |
| INSMED INC INSM 1.75 01.15.25 · principal | $98.2m2.10% | Unchanged |
| DECIPHERA PHARMACEUTICALS IN DCPH | $94.4m2.02% | Added +1.5m |
| INTERCEPT PHARMACEUTICALS IN ICPT 3.5 02.15.26 · principal | $94.0m2.01% | Unchanged |
| CENTENE CORP DEL CNC | $91.0m1.94% | Added +274.0k |
| OWENS & MINOR INC NEW ACH | $90.3m1.93% | Added +877.5k |
| MERUS N V MRUS | $79.8m1.70% | Added +651.5k |
| ARS PHARMACEUTICALS INC SPRY | $74.2m1.58% | Unchanged |
| GUARDANT HEALTH INC GH 0 11.15.27 · principal | $63.9m1.36% | Unchanged |
| HILLEVAX INC COM | $57.2m1.22% | Added +495.5k |
| ENHABIT INC EHAB | $55.3m1.18% | Added +1.4m |
| NANOSTRING TECHNOLOGIES INC NSTG 2.625 03.01.25 · principal | $54.8m1.17% | Unchanged |
| BROOKDALE SR LIVING INC BKD | $53.5m1.14% | Reduced -3.7m |
| IDEAYA BIOSCIENCES INC IDYA | $53.3m1.14% | Added +525.0k |
| LARIMAR THERAPEUTICS INC LRMR | $53.0m1.13% | Unchanged |
| CAREMAX INC COM CL A | $49.3m1.05% | Unchanged |
| REVOLUTION MEDICINES INC RVMD | $46.9m1.00% | Added +921.8k |
| LIVONGO HEALTH INC TDOC 0.875 06.01.25 · principal | $45.2m0.96% | Unchanged |
| GUARDANT HEALTH INC GH | $44.9m0.96% | Added +475.0k |
| SPRINGWORKS THERAPEUTICS INC SWTX | $41.4m0.88% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $39.9m0.85% | Added +400.0k |
| SILK RD MED INC SILK | $36.8m0.79% | Reduced -593.4k |
| KURA ONCOLOGY INC KURA | $34.3m0.73% | Added +855.0k |
| PTC THERAPEUTICS INC PTCT 1.5 09.15.26 · principal | $33.0m0.70% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $30.5m0.65% | Unchanged |
| CABALETTA BIO INC CABA | $30.2m0.64% | Added +1.9m |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $30.1m0.64% | Unchanged |
| DOCGO INC DCGO | $28.7m0.61% | Unchanged |
| HEALTH CATALYST INC HCAT 2.5 04.15.25 · principal | $28.6m0.61% | Unchanged |
| APELLIS PHARMACEUTICALS INC APLS | $28.5m0.61% | New |
| STRUCTURE THERAPEUTICS INC GPCR | $26.1m0.56% | Added +252.8k |
| INTERCEPT PHARMACEUTICALS IN ICPT | $23.0m0.49% | New |
| AMYLYX PHARMACEUTICALS INC AMLX | $22.7m0.48% | Reduced -934.1k |
| REVANCE THERAPEUTICS INC RVNC | $22.0m0.47% | New |
| XERIS BIOPHARMA HOLDINGS INC XERS 5 07.15.25 · principal | $21.4m0.46% | Unchanged |
| ALPHATEC HLDGS INC ATEC | $21.4m0.46% | Added +142.9k |
| VENTYX BIOSCIENCES INC VTYX | $20.2m0.43% | Unchanged |
| VIGIL NEUROSCIENCE INC VIGL | $19.3m0.41% | Unchanged |
| DISC MEDICINE INC IRON | $19.1m0.41% | New |
| VIKING THERAPEUTICS INC VKTX | $18.2m0.39% | Unchanged |
| DENALI THERAPEUTICS INC DNLI | $17.6m0.37% | Unchanged |
| TERNS PHARMACEUTICALS INC COM | $16.6m0.35% | Reduced -160.7k |
| DA32 LIFE SCNCE TEC ACQSTN C CLASS A COM | $16.4m0.35% | Unchanged |
| INVITAE CORP NVTA 2 09.01.24 · principal | $15.3m0.33% | Added +1.5m |
| DAY ONE BIOPHARMACEUTICALS I COM | $15.2m0.32% | New |
| MINERALYS THERAPEUTICS INC MLYS | $14.3m0.30% | Added +108.0k |
| PULMONX CORP LUNG | $14.0m0.30% | Reduced -1.3m |
| INSMED INC INSM | $13.9m0.30% | Unchanged |
| ROIVANT SCIENCES LTD ROIV | $13.7m0.29% | Reduced -395.0k |
| ACELYRIN INC COM | $13.6m0.29% | New |
| FUSION PHARMACEUTICALS INC COM | $13.2m0.28% | Unchanged |
| THESEUS PHARMACEUTICALS INC COM | $13.1m0.28% | New |
| PRIME MEDICINE INC PRME | $13.0m0.28% | Unchanged |
| ANAPTYSBIO INC ANAB | $12.5m0.27% | Unchanged |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $11.7m0.25% | New |
| VERASTEM INC VSTM | $11.4m0.24% | New |
| AXONICS INC AXNX | $11.4m0.24% | New |
| ALIGNMENT HEALTHCARE INC ALHC | $10.6m0.23% | New |
| NUVATION BIO INC NUVB | $10.5m0.22% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $9.5m0.20% | New |
| PHATHOM PHARMACEUTICALS INC PHAT | $9.4m0.20% | New |
| BIOCRYST PHARMACEUTICALS INC BCRX | $9.3m0.20% | Reduced -1.4m |
| BLACK DIAMOND THERAPEUTICS I BDTX | $9.1m0.19% | New |
| GENEDX HOLDINGS CORP WGS | $7.5m0.16% | New |
| ALECTOR INC ALEC | $6.3m0.14% | Unchanged |
| NEOGENOMICS INC NEO 1.25 05.01.25 · principal | $6.1m0.13% | Unchanged |
| FOGHORN THERAPEUTICS INC FHTX | $5.5m0.12% | Unchanged |
| SINGULAR GENOMICS SYSTEMS IN COM | $5.4m0.11% | Unchanged |
| NYXOAH S A NYXH | $3.6m0.08% | Unchanged |
| ABEONA THERAPEUTICS INC ABEO | $3.5m0.07% | Unchanged |
| ROIVANT SCIENCES LTD *W EXP 09/30/202 | $2.5m0.05% | Unchanged |
| ACUTUS MED INC AFIB | $2.4m0.05% | Added +9.1k |
| ELEVATION ONCOLOGY INC COM | $2.1m0.04% | New |
| ANNEXON INC ANNX | $2.1m0.04% | Unchanged |
| THE ONCOLOGY INSTITUTE INC STLN | $1.8m0.04% | Unchanged |
| ORCHARD THERAPEUTICS PLC SPON ADS NEW | $1.6m0.04% | Unchanged |
| QUANTUM SI INC QSI | $1.4m0.03% | New |
| CALCIMEDICA INC COM NEW | $1.1m0.02% | New |
| CAREMAX INC *W EXP 06/08/202 | $259.4k0.01% | Unchanged |
| MEDAVAIL HOLDINGS INC MYOS | $205.1k0.00% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $193.9k0.00% | Unchanged |
| BUTTERFLY NETWORK INC BFLYW | $172.7k0.00% | Unchanged |
| QUANTUM SI INC *W EXP 06/10/202 | $76.7k0.00% | Unchanged |
| THE ONCOLOGY INSTITUTE INC STLNW | $34.9k0.00% | Unchanged |
| SOMALOGIC INC *W EXP 08/31/202 | $30.0k0.00% | Unchanged |
| SIENTRA INC SIEN | $29.3k0.00% | Unchanged |
| NUVATION BIO INC NUVB.WS | $27.6k0.00% | Unchanged |
| MEDTECH ACQUISITION CORP *W EXP 12/22/202 | $14.0k0.00% | Unchanged |
| SURROZEN INC *W EXP 08/01/203 | $9.2k0.00% | Unchanged |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| APELLIS PHARMACEUTICALS INC APLS 3.5 09.15.26 | $96.0m51.8m shares |
| PACIRA BIOSCIENCES INC PCRX 0.75 08.01.25 | $75.0m81.6m shares |
| INTERCEPT PHARMACEUTICALS IN ICPT 3.25 07.01.23 | $57.0m57.8m shares |
| MIRUM PHARMACEUTICALS INC MIRM | $48.8m2.0m shares |
| INTRA-CELLULAR THERAPIES INC ITCI | $39.7m734.0k shares |
| IVERIC BIO INC OPHT | $36.6m1.5m shares |
| EVOLUS INC EOLS | $30.2m3.6m shares |
| BELLUS HEALTH INC NEW BLU | $25.8m3.6m shares |
| KRYSTAL BIOTECH INC KRYS | $25.0m311.9k shares |
| SEMA4 HOLDINGS CORP SMFR | $20.9m57.2m shares |
| OAK STR HEALTH INC OSH 0 03.15.26 | $15.2m15.4m shares |
| TARSUS PHARMACEUTICALS INC TARS | $14.5m1.2m shares |
| INVITAE CORP NVTA | $12.5m9.3m shares |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $11.2m1.8m shares |
| VAXCYTE INC PCVX | $11.1m295.0k shares |
| VERA THERAPEUTICS INC VERA | $10.1m1.3m shares |
| PACIFIC BIOSCIENCES CALIF IN PACB | $7.5m650.0k shares |
| BLUEBIRD BIO INC | $6.9m2.2m shares |
| CASTLE BIOSCIENCES INC CSTL | $6.2m272.1k shares |
| RAIN ONCOLOGY INC | $2.0m227.4k shares |
| SENIOR CONNECT ACQUISITN COR | $19.6k500.0k shares |
| EUCRATES BIOMEDICAL ACQU COR | $13.5k333.3k shares |
| EUCRATES BIOMEDICAL ACQU COR | $101 shares |